Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MARaviroc-based Treatment Switch in HIV-positive Patients With HAND: Consequences of Reducing Antiretroviral-associated Neurotoxicity

NCT03163277 is registered in ClinicalTrials.gov with Giovanni Di Perri as lead sponsor.

NCT NCT03163277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03163277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MARaviroc-based Treatment Switch in HIV-positive Patients With HAND: Consequences of Reducing Antiretroviral-associated Neurotoxicity
Lead sponsor
Giovanni Di Perri
Phase
Phase 4
Overall status
Terminated
Start date
May 15, 2017
Completion date
June 30, 2020
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, neurocognitive dysfunction